Comprehensive Stool Analysis

The Comprehensive Digestive Stool Analysis 2.0 (CDSA 2.0) is the most advanced and complete non-invasive evaluation of specific gastrointestinal (GI) tract imbalances. This comprehensive test evaluates digestion, absorption, gut flora, and the colonic environment, and is indicated for all chronic GI problems, for acute bowel pattern changes, and for many systemic diseases. Additionally, this test offers a parasitological component that evaluates for parasites using microscopic examination and EIA testing.

In addition to identifying general dysfunction, this analysis provides direct measures to pinpoint the diagnosis and treatment of patients with many digestive conditions including Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD), and common symptoms such as abdominal pain, indegestion, heartburn, gas and bloating, diarrhea, and constipation.
Digestive symptoms are among the most common reasons that individuals seek medical care. The integrity and health of the gastrointestinal system is not only responsible for proper digestion and absorption of nutrients, but also for proper immune system function; therefore, GI abnormalities are associated with many chronic conditions (diseases) in other regions of the body.

Specific Indicators for Testing

Gas or Bloating
Bloody Stool
Antibiotic or Pain (NSAID) Medication Use
Irritable Bowel Syndrome
Crohn’s Disease or Ulcerative Colitis
Family History of GI Cancers
Autoimmune Disease
Chronic Fatigue
Detect Early Warning Signs of Colon Cancer -
Deferentiate Between Irritable Bowel Syndrome and Inflammatory Bowel Disease - Find Underlying Reasons for Chronic Diseases
Comprehensive Digestive Stool Analysis 2.0 Includes:

Digestion/Absorption Markers: (Pancreatic Elastase, Putrefactive SCFAs, n-Butyrate)
Pancreatic Digestive Enzymes
Stool Transit Time (gut motility)

Gut Immunology Markers: (Calprotectin, Eosinophil Protein X)
Mild, Moderate or Severe Inflammation
Bacterial, Viral and Parasitic Infections
Food Allergies
Inflammatory Bowel Disease
Cancer Markers (early warning signs)
Drug (NSAID) Induced Dysfunction

Metabolic Markers: (Short Chain Fatty Acids, pH, Beta-glucuronidase, Bile Acids)
Gut Flora (friendly bacteria) Abnormalities
Dietary Fiber Deficiency
Bacteria Overgrowth
Altered Transit Time (gut motility)
Toxic Burden (Colon and Breast Cancer Risk)

Microbiology Markers: (Bacteriology, Mycology)
Lactobacillus and Bifidobacterium Assessment
Pathogenic Bacteria and Yeast

Parasitology: (EIA and microscopic evaluation)
Ova and Parasites Identified
Microscopic Evaluation for Yeast and Blood Cells.